Valuation: Dermapharm Holding SE

Market Cap 2.03B 2.34B 1.89B 1.74B 3.28B 223B 3.33B 22.29B 8.75B 111B 8.78B 8.58B 372B P/E 2026 *
15.4x
P/E 2027 * 14x
Enterprise Value 2.82B 3.25B 2.63B 2.41B 4.56B 310B 4.63B 30.98B 12.16B 154B 12.2B 11.93B 518B EV / Sales 2026 *
2.34x
EV / Sales 2027 * 2.13x
Free-Float
10.7%
Yield 2026 *
2.48%
Yield 2027 * 2.74%
1 day-1.22%
1 week+1.74%
1 month-12.67%
3 months-11.54%
6 months+16.81%
Current year+4.19%
1 week 40.65
Extreme 40.65
43.3
1 month 39.95
Extreme 39.95
47.6
Current year 34.3
Extreme 34.3
51.9
1 year 31.7
Extreme 31.7
51.9
3 years 30.15
Extreme 30.15
51.9
5 years 30.15
Extreme 30.15
91.95
10 years 21.58
Extreme 21.575
91.95
Manager TitleAgeSince
Chief Executive Officer 64 01/08/2017
Director of Finance/CFO - 01/11/2022
Investor Relations Contact - 01/12/2018
Director TitleAgeSince
Chairman 70 01/08/2017
Director/Board Member 66 01/08/2017
Director/Board Member 77 01/01/2018
Date Insider Type Main position Quantity % Market Cap.
07/01/26 Buy 150 0.0003%
07/01/26 Buy 150 0.0003%
07/01/26 Buy 2,050 0.0038%
Change 5-day change 1-year change 3-year change Capi.($)
-1.91%+1.74%+23.49%-4.47% 2.34B
-0.53%-3.95%+50.70%+152.78% 1,024B
+0.21%-2.68%+53.20%+50.87% 618B
-2.51%-3.25%+28.54%+67.99% 443B
+0.06%-0.42%+37.53%+31.06% 349B
-0.14%-0.24%+34.41%+39.49% 297B
-0.69%-0.30%+13.76%+13.84% 264B
-7.37%-4.40%-0.74%-43.66% 209B
-0.64%+2.43%+29.74%+67.16% 208B
-0.82%+0.70%+15.05%+72.05% 162B
Average -1.37%-1.04%+28.57%+44.71% 357.61B
Weighted average by Cap. -0.99%-2.16%+37.17%+72.93%

Financials

2026 *2027 *
Net sales 1.21B 1.39B 1.12B 1.03B 1.95B 133B 1.98B 13.26B 5.2B 66.07B 5.22B 5.11B 222B 1.25B 1.44B 1.17B 1.07B 2.02B 138B 2.06B 13.76B 5.4B 68.58B 5.42B 5.3B 230B
Net income 139M 160M 129M 119M 224M 15.26B 228M 1.53B 599M 7.6B 601M 587M 25.48B 155M 178M 144M 133M 250M 17.04B 254M 1.7B 668M 8.48B 670M 656M 28.44B
Net Debt 792M 911M 737M 677M 1.28B 86.98B 1.3B 8.69B 3.41B 43.3B 3.42B 3.35B 145B 636M 731M 592M 543M 1.03B 69.79B 1.04B 6.97B 2.74B 34.74B 2.75B 2.69B 117B
Logo Dermapharm Holding SE
Dermapharm Holding SE is a Germany-based company engaged in manufacturing of patent-free branded pharmaceuticals. The Company operates through two segments: Branded pharmaceuticals and other healthcare products, which includes in-house development, in-house production, and distribution of branded pharmaceuticals and other healthcare products, and Parallel import business, which operates under the axicorp brand. It holds around 950 marketing authorizations for more than 250 active pharmaceutical ingredients, which are marketed as pharmaceuticals, dietary supplements or supplemental balanced diets. The Company offers its products through a number of brands, including Dekristol, Ampho Moronal, Keltican, Tromcardin, among others. It is active primarily in Germany, Switzerland and Austria. Additionally, it operates production facility in Germany. Trommsdorff & GmbH Co KG is a subsidiary of the Company.
Employees
3,503
Date Price Change Volume
31/07/26 €41.00 -1.91% 26,557
30/07/26 €41.80 -2.45% 19,427
29/07/26 €42.85 +2.63% 14,146
28/07/26 €41.75 +2.45% 23,019
27/07/26 €40.75 +1.12% 31,898
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
6
Last Close Price
41.00EUR
Average target price
50.38EUR
Spread / Average Target
+22.87%

Quarterly revenue - Rate of surprise